Similar content being viewed by others Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of medication that mimic the effects of glucagon-like peptide-1 (GLP-1), an endogenous, gut-derived incretin that is released in response to a meal [1]
Network meta-analysis research found that oral semaglutide 14mg produced HbA1c reductions of 0.42-1.32% compared to other injectable GLP-1 medications, with no statistically significant difference when compared to injectable semaglutide 0.5mg and 1mg doses
Associated Anomalies Approximately 29% of clefts are linked to other anomalies or syndromes: Van der Woude Syndrome : Caused by IRF6 gene mutations, characterized by cleft lip/palate and lower lip pits
fruit: proposed mechanisms
Southwest Chopped Salad (from HFLM!) This salad packs a ton of fiber and color, thanks to beans, corn, red peppers, cucumbers, and tomatoes